查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1734917

2032 年栓塞颗粒市场预测：按产品、材料、应用、最终用户和地区进行的全球分析

Embolization Particle Market Forecasts to 2032 - Global Analysis By Product (Radioembolization Spheres, Microspheres, Drug Eluting Beads, Gelfoam Particles, Gelatin Sponge Particles and Other Products), Material, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球栓塞颗粒市场预计在 2025 年达到 17 亿美元，到 2032 年将达到 38 亿美元，预测期内的复合年增长率为 12.7%。

栓塞颗粒是一种小型合成或天然材料，用于栓塞术（一种用于故意阻塞血管的医疗程序）。这些颗粒透过导管注入目标血管，以阻断流向特定区域的血流，例如肿瘤、异常生长或出血部位。限制血液供应可以缩小肿瘤、止血或减少术中出血。常用材料包括聚乙烯醇 (PVA)、微球、明胶海绵和金属线圈。颗粒大小和材料的选择取决于临床目标和目标血管的大小。

根据美国癌症协会2024年1月发布的数据，预计当年美国将诊断出约41,630例新的肝癌病例。

慢性病增多

癌症、心血管疾病和子宫肌瘤等慢性疾病发生率的上升，推动了栓塞颗粒市场的显着成长。这些疾病通常需要微创手术进行治疗，而栓塞颗粒在阻断异常血流方面发挥关键作用。随着患者对微创、更有针对性且恢復治疗方法更快的治疗方案的需求不断增长，对栓塞技术的需求也日益增长。这一趋势正在推动创新、投资和市场扩张，使栓塞颗粒成为关键的治疗方案。

栓塞治疗高成本

栓塞手术的高昂成本是栓塞颗粒市场成长的主要障碍。高昂的治疗费用限制了患者（尤其是在低收入地区）的就医管道，从而降低了整体需求。此外，由于营运成本高昂，医疗保健提供者可能不愿采用这些先进的手术，这进一步阻碍了市场扩张。这为市场进入者设置了障碍，减缓了创新，并限制了可能挽救生命的治疗方法的采用。

技术进步

技术进步显着推动了栓塞颗粒市场的发展，提高了精准度、疗效和病患安全性。影像导引输送系统、生物可吸收颗粒和奈米技术等创新技术实现了微创标标靶治疗，缩短了恢復时间，并改善了治疗效果。这些突破性技术正在吸引投资，并拓展了肿瘤科、神经科、妇科等领域的临床应用。随着医疗保健向个人化医疗转变，技术主导的栓塞解决方案提供了更高的客製化能力，推动了其在全球范围内的广泛应用和市场成长。

严格的监管要求

严格的监管要求是栓塞颗粒市场发展的一大障碍，核准流程冗长且成本高昂。 FDA 和 EMA 等监管机构要求进行广泛的临床试验并获得全面的安全数据，这减缓了新产品的上市速度。这些严格的标准增加了开发成本，并使合规性变得复杂，尤其对于中小型製造商而言。这些障碍限制了创新，限制了产品的可近性，阻碍了人们及时获得先进疗法，尤其是在新兴市场。

COVID-19的影响

新冠疫情严重扰乱了栓塞颗粒市场，导致择期手术延误，住院人数减少。封锁和资源重新分配使供应链紧张，为生产和分销带来了挑战。这导致劳动力短缺，并阻碍了临床开发活动。因此，在疫情高峰期，市场成长放缓。然而，随着医疗体系的调整和择期手术的恢復，市场有望復苏并继续扩张。

预计在预测期内，生物分解性材料市场将成长至最大

预计生物分解性材料将在预测期内占据最大的市场占有率，因为这些颗粒在达到治疗效果后会自然溶解，从而最大限度地降低永久性植入的风险。人们对微创手术的偏好日益增长，以及对生物相容性的认识不断提高，推动了这项需求。此外，生物分解性材料的进步提高了治疗的精准度和术后恢復，使其成为栓塞颗粒产业技术创新的主要驱动力和催化剂。

预计在预测期内，神经病学领域将以最高的复合年增长率成长。

由于动静脉畸形等神经血管疾病的发生率上升，预计神经内科领域将在预测期内达到最高成长率。微创手术的进步以及人们对神经系统疾病认识的不断提高，刺激了对精准栓塞解决方案的需求。医院和诊所越来越多地采用栓塞颗粒进行有效且有针对性的治疗，从而改善患者的治疗效果。神经内科领域的强劲需求将继续对全球栓塞技术市场的扩张、创新和投资产生积极影响。

占比最大的地区：

在预测期内，由于先进介入放射学手术的普及，亚太地区预计将占据最大的市场占有率。世界各国政府都优先考虑微创手术，这推动了栓塞治疗的需求。技术进步和医疗旅游业的蓬勃发展也促进了市场扩张。中国、印度和东南亚等新兴经济体正在推动改善患者预后、缩短復原时间并提供经济高效的医疗解决方案。

复合年增长率最高的地区：

由于微创技术的日益普及以及介入放射技术的进步，预计北美地区在预测期内的复合年增长率最高。医疗支出和报销政策的不断增加进一步推动了市场的成长。领先的公司正在投资研发，以提高治疗的有效性和安全性。这些进步正在改善患者的治疗效果，并加速治疗需求的成长，从而巩固该地区在全球栓塞技术领域的领导地位。

免费客製化服务：

订阅此报告的客户可以选择以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球栓塞颗粒市场（按产品）

  • 放射栓塞球
  • 微球
  • 药物释放型珠（DEB）
  • 明胶海绵颗粒
  • 明胶海绵颗粒
  • 液体栓子
  • 聚乙烯醇（PVA）颗粒
  • 其他产品

6. 全球栓塞颗粒市场（依材料）

  • 生物分解性
  • 生物分解性

7. 全球栓塞颗粒市场（依应用）

  • 肿瘤学
  • 泌尿系统
  • 神经病学
  • 週边血管疾病
  • 其他用途

8. 全球栓塞颗粒市场（依最终用户）

  • 医院
  • 门诊手术中心
  • 诊所
  • 其他最终用户

9. 全球栓塞颗粒市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Boston Scientific Corporation
  • Medtronic plc
  • Terumo Corporation
  • Merit Medical Systems, Inc.
  • Cook Medical Inc.
  • Sirtex Medical Limited
  • BTG plc
  • Stryker Corporation
  • Penumbra, Inc.
  • Johnson & Johnson
  • Guerbet Group
  • Kaneka Corporation
  • Interface BIOmaterials BV
  • HENGRUI Medical
  • Alicon
Product Code: SMRC29554

According to Stratistics MRC, the Global Embolization Particle Market is accounted for $1.7 billion in 2025 and is expected to reach $3.8 billion by 2032 growing at a CAGR of 12.7% during the forecast period. Embolization particles are small synthetic or natural materials used in a medical procedure called embolization to block blood vessels deliberately. These particles are injected through a catheter into the targeted blood vessels to obstruct blood flow to specific areas, such as tumors, abnormal growths, or areas of bleeding. By restricting blood supply, embolization can shrink tumors, stop hemorrhaging, or reduce blood loss during surgery. Common materials include polyvinyl alcohol (PVA), microspheres, gelatin sponges, or metal coils. The choice of particle size and material depends on the clinical goal and target vessel size.

According to data published by the American Cancer Society, Inc., in January 2024, about 41,630 new liver cancer cases were estimated to be diagnosed in the U.S. that year.

Market Dynamics:

Driver:

Rising Incidence of Chronic Diseases

The rising incidence of chronic diseases such as cancer, cardiovascular conditions, and uterine fibroids is driving significant growth in the embolization particle market. These conditions often require minimally invasive procedures for treatment, where embolization particles play a crucial role in blocking abnormal blood flow. As patient demand increases for less invasive, targeted therapies with faster recovery times, the need for embolization technologies expands. This trend fosters innovation, investment, and market expansion, positioning embolization particles as a key therapeutic solution.

Restraint:

High Cost of Embolization Procedures

The high cost of embolization procedures significantly hinders the growth of the embolization particle market. Expensive treatment prices limit patient accessibility, particularly in low-income regions, reducing overall demand. Additionally, healthcare providers may be reluctant to adopt these advanced procedures due to high operational costs, further stalling market expansion. This creates a barrier for market players, slowing innovation and limiting the adoption of potentially life-saving treatments.

Opportunity:

Technological Advancements

Technological advancements are significantly driving the embolization particle market by enhancing precision, efficacy, and patient safety. Innovations such as image-guided delivery systems, bioresorbable particles, and nanotechnology enable targeted therapy with minimal invasiveness, reducing recovery time and improving outcomes. These breakthroughs attract investment and expand clinical applications across oncology, neurology, and gynecology. As healthcare shifts toward personalized medicine, technology-driven embolization solutions offer superior customization, boosting adoption and market growth globally.

Threat:

Stringent Regulatory Requirements

Stringent regulatory requirements significantly hinder the embolization particle market by imposing lengthy and costly approval processes. Regulatory bodies like the FDA and EMA demand extensive clinical trials and comprehensive safety data, delaying market entry for new products. These rigorous standards increase development costs and complicate compliance, particularly for small and mid-sized manufacturers. Such barriers restrict innovation, limit product availability, and impede timely access to advanced treatments, especially in emerging markets.

Covid-19 Impact

The COVID-19 pandemic significantly disrupted the embolization particle market, leading to delays in elective procedures and reduced hospital admissions. Lockdowns and resource reallocation strained supply chains, causing manufacturing and distribution challenges. This resulted in workforce shortages and hindered clinical development activities. Consequently, the market experienced a slowdown in growth during the peak of the pandemic. However, as healthcare systems adapt and elective procedures resume, the market is poised for recovery and continued expansion.

The biodegradable segment is expected to be the largest during the forecast period

The biodegradable segment is expected to account for the largest market share during the forecast period as these particles naturally dissolve after achieving their therapeutic effect, minimizing risks associated with permanent implants. Growing preference for minimally invasive procedures and increasing awareness of biocompatibility are fueling demand. Additionally, advancements in biodegradable materials enhance treatment precision and post-procedural recovery, positioning this segment as a key growth driver and innovation catalyst within the embolization particle industry.

The neurology segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the neurology segment is predicted to witness the highest growth rate, due to rising incidences of neurovascular disorders such as arteriovenous malformations. Advancements in minimally invasive procedures and increased awareness of neurological conditions have spurred demand for precise embolization solutions. Hospitals and clinics are increasingly adopting embolization particles for effective, targeted treatments, enhancing patient outcomes. This strong demand from the neurology field continues to positively impact market expansion, innovation, and investment in embolic technologies globally.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to improved access to advanced interventional radiology procedures. Governments are prioritizing minimally invasive treatments, boosting demand for embolization therapies. Technological advancements and expanding medical tourism further contribute to market expansion. This positive momentum is enhancing patient outcomes, reducing recovery times, and promoting cost-effective healthcare solutions across rapidly developing economies like China, India, and Southeast Asia.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to rising adoption of minimally invasive procedures, and technological advancements in interventional radiology. Growing healthcare expenditure and supportive reimbursement policies further drive market growth. Major players are investing in research and development, enhancing treatment efficacy and safety. This progress fosters better patient outcomes, accelerates procedural demand, and strengthens the region's leadership in global embolization technologies.

Key players in the market

Some of the key players profiled in the Embolization Particle Market include Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Merit Medical Systems, Inc., Cook Medical Inc., Sirtex Medical Limited, BTG plc, Stryker Corporation, Penumbra, Inc., Johnson & Johnson, Guerbet Group, Kaneka Corporation, Interface BIOmaterials B.V., HENGRUI Medical and Alicon.

Key Developments:

In February 2025, Medtronic and Philips have partnered to enhance the capabilities of over 300 clinicians in India by providing advanced training in structural heart imaging. This collaboration focuses on equipping cardiologists and radiologists with expertise in multi-modality imaging techniques, particularly echocardiography (echo) and Magnetic Resonance Imaging (MRI), to improve the diagnosis and treatment of structural heart diseases, especially among End-Stage Renal Disease (ESRD) patients.

In July 2024, Medtronic and SWIZTON Medcare have inaugurated their first collaborative vein clinic at Aveksha Hospital in Singapura, Bengaluru. This facility aims to provide accessible and advanced treatments for varicose veins, a condition affecting approximately 20% of adults globally.

Products Covered:

  • Radioembolization Spheres
  • Microspheres
  • Drug Eluting Beads (DEBs)
  • Gelfoam Particles
  • Gelatin Sponge Particles
  • Liquid Embolics
  • Polyvinyl Alcohol (PVA) Particles
  • Other Products

Materials Covered:

  • Biodegradable
  • Non-biodegradable

Applications Covered:

  • Oncology
  • Urology
  • Neurology
  • Peripheral Vascular Disease
  • Other Applications

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Embolization Particle Market, By Product

  • 5.1 Introduction
  • 5.2 Radioembolization Spheres
  • 5.3 Microspheres
  • 5.4 Drug Eluting Beads (DEBs)
  • 5.5 Gelfoam Particles
  • 5.6 Gelatin Sponge Particles
  • 5.7 Liquid Embolics
  • 5.8 Polyvinyl Alcohol (PVA) Particles
  • 5.9 Other Products

6 Global Embolization Particle Market, By Material

  • 6.1 Introduction
  • 6.2 Biodegradable
  • 6.3 Non-biodegradable

7 Global Embolization Particle Market, By Application

  • 7.1 Introduction
  • 7.2 Oncology
  • 7.3 Urology
  • 7.4 Neurology
  • 7.5 Peripheral Vascular Disease
  • 7.6 Other Applications

8 Global Embolization Particle Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Ambulatory Surgical Centers
  • 8.4 Clinics
  • 8.5 Other End Users

9 Global Embolization Particle Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Boston Scientific Corporation
  • 11.2 Medtronic plc
  • 11.3 Terumo Corporation
  • 11.4 Merit Medical Systems, Inc.
  • 11.5 Cook Medical Inc.
  • 11.6 Sirtex Medical Limited
  • 11.7 BTG plc
  • 11.8 Stryker Corporation
  • 11.9 Penumbra, Inc.
  • 11.10 Johnson & Johnson
  • 11.11 Guerbet Group
  • 11.12 Kaneka Corporation
  • 11.13 Interface BIOmaterials B.V.
  • 11.14 HENGRUI Medical
  • 11.15 Alicon

List of Tables

  • Table 1 Global Embolization Particle Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Embolization Particle Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Embolization Particle Market Outlook, By Radioembolization Spheres (2024-2032) ($MN)
  • Table 4 Global Embolization Particle Market Outlook, By Microspheres (2024-2032) ($MN)
  • Table 5 Global Embolization Particle Market Outlook, By Drug Eluting Beads (DEBs) (2024-2032) ($MN)
  • Table 6 Global Embolization Particle Market Outlook, By Gelfoam Particles (2024-2032) ($MN)
  • Table 7 Global Embolization Particle Market Outlook, By Gelatin Sponge Particles (2024-2032) ($MN)
  • Table 8 Global Embolization Particle Market Outlook, By Liquid Embolics (2024-2032) ($MN)
  • Table 9 Global Embolization Particle Market Outlook, By Polyvinyl Alcohol (PVA) Particles (2024-2032) ($MN)
  • Table 10 Global Embolization Particle Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 11 Global Embolization Particle Market Outlook, By Material (2024-2032) ($MN)
  • Table 12 Global Embolization Particle Market Outlook, By Biodegradable (2024-2032) ($MN)
  • Table 13 Global Embolization Particle Market Outlook, By Non-biodegradable (2024-2032) ($MN)
  • Table 14 Global Embolization Particle Market Outlook, By Application (2024-2032) ($MN)
  • Table 15 Global Embolization Particle Market Outlook, By Oncology (2024-2032) ($MN)
  • Table 16 Global Embolization Particle Market Outlook, By Urology (2024-2032) ($MN)
  • Table 17 Global Embolization Particle Market Outlook, By Neurology (2024-2032) ($MN)
  • Table 18 Global Embolization Particle Market Outlook, By Peripheral Vascular Disease (2024-2032) ($MN)
  • Table 19 Global Embolization Particle Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 20 Global Embolization Particle Market Outlook, By End User (2024-2032) ($MN)
  • Table 21 Global Embolization Particle Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 22 Global Embolization Particle Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 23 Global Embolization Particle Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 24 Global Embolization Particle Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 25 North America Embolization Particle Market Outlook, By Country (2024-2032) ($MN)
  • Table 26 North America Embolization Particle Market Outlook, By Product (2024-2032) ($MN)
  • Table 27 North America Embolization Particle Market Outlook, By Radioembolization Spheres (2024-2032) ($MN)
  • Table 28 North America Embolization Particle Market Outlook, By Microspheres (2024-2032) ($MN)
  • Table 29 North America Embolization Particle Market Outlook, By Drug Eluting Beads (DEBs) (2024-2032) ($MN)
  • Table 30 North America Embolization Particle Market Outlook, By Gelfoam Particles (2024-2032) ($MN)
  • Table 31 North America Embolization Particle Market Outlook, By Gelatin Sponge Particles (2024-2032) ($MN)
  • Table 32 North America Embolization Particle Market Outlook, By Liquid Embolics (2024-2032) ($MN)
  • Table 33 North America Embolization Particle Market Outlook, By Polyvinyl Alcohol (PVA) Particles (2024-2032) ($MN)
  • Table 34 North America Embolization Particle Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 35 North America Embolization Particle Market Outlook, By Material (2024-2032) ($MN)
  • Table 36 North America Embolization Particle Market Outlook, By Biodegradable (2024-2032) ($MN)
  • Table 37 North America Embolization Particle Market Outlook, By Non-biodegradable (2024-2032) ($MN)
  • Table 38 North America Embolization Particle Market Outlook, By Application (2024-2032) ($MN)
  • Table 39 North America Embolization Particle Market Outlook, By Oncology (2024-2032) ($MN)
  • Table 40 North America Embolization Particle Market Outlook, By Urology (2024-2032) ($MN)
  • Table 41 North America Embolization Particle Market Outlook, By Neurology (2024-2032) ($MN)
  • Table 42 North America Embolization Particle Market Outlook, By Peripheral Vascular Disease (2024-2032) ($MN)
  • Table 43 North America Embolization Particle Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 44 North America Embolization Particle Market Outlook, By End User (2024-2032) ($MN)
  • Table 45 North America Embolization Particle Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 46 North America Embolization Particle Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 47 North America Embolization Particle Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 48 North America Embolization Particle Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 49 Europe Embolization Particle Market Outlook, By Country (2024-2032) ($MN)
  • Table 50 Europe Embolization Particle Market Outlook, By Product (2024-2032) ($MN)
  • Table 51 Europe Embolization Particle Market Outlook, By Radioembolization Spheres (2024-2032) ($MN)
  • Table 52 Europe Embolization Particle Market Outlook, By Microspheres (2024-2032) ($MN)
  • Table 53 Europe Embolization Particle Market Outlook, By Drug Eluting Beads (DEBs) (2024-2032) ($MN)
  • Table 54 Europe Embolization Particle Market Outlook, By Gelfoam Particles (2024-2032) ($MN)
  • Table 55 Europe Embolization Particle Market Outlook, By Gelatin Sponge Particles (2024-2032) ($MN)
  • Table 56 Europe Embolization Particle Market Outlook, By Liquid Embolics (2024-2032) ($MN)
  • Table 57 Europe Embolization Particle Market Outlook, By Polyvinyl Alcohol (PVA) Particles (2024-2032) ($MN)
  • Table 58 Europe Embolization Particle Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 59 Europe Embolization Particle Market Outlook, By Material (2024-2032) ($MN)
  • Table 60 Europe Embolization Particle Market Outlook, By Biodegradable (2024-2032) ($MN)
  • Table 61 Europe Embolization Particle Market Outlook, By Non-biodegradable (2024-2032) ($MN)
  • Table 62 Europe Embolization Particle Market Outlook, By Application (2024-2032) ($MN)
  • Table 63 Europe Embolization Particle Market Outlook, By Oncology (2024-2032) ($MN)
  • Table 64 Europe Embolization Particle Market Outlook, By Urology (2024-2032) ($MN)
  • Table 65 Europe Embolization Particle Market Outlook, By Neurology (2024-2032) ($MN)
  • Table 66 Europe Embolization Particle Market Outlook, By Peripheral Vascular Disease (2024-2032) ($MN)
  • Table 67 Europe Embolization Particle Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 68 Europe Embolization Particle Market Outlook, By End User (2024-2032) ($MN)
  • Table 69 Europe Embolization Particle Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 70 Europe Embolization Particle Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 71 Europe Embolization Particle Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 72 Europe Embolization Particle Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 73 Asia Pacific Embolization Particle Market Outlook, By Country (2024-2032) ($MN)
  • Table 74 Asia Pacific Embolization Particle Market Outlook, By Product (2024-2032) ($MN)
  • Table 75 Asia Pacific Embolization Particle Market Outlook, By Radioembolization Spheres (2024-2032) ($MN)
  • Table 76 Asia Pacific Embolization Particle Market Outlook, By Microspheres (2024-2032) ($MN)
  • Table 77 Asia Pacific Embolization Particle Market Outlook, By Drug Eluting Beads (DEBs) (2024-2032) ($MN)
  • Table 78 Asia Pacific Embolization Particle Market Outlook, By Gelfoam Particles (2024-2032) ($MN)
  • Table 79 Asia Pacific Embolization Particle Market Outlook, By Gelatin Sponge Particles (2024-2032) ($MN)
  • Table 80 Asia Pacific Embolization Particle Market Outlook, By Liquid Embolics (2024-2032) ($MN)
  • Table 81 Asia Pacific Embolization Particle Market Outlook, By Polyvinyl Alcohol (PVA) Particles (2024-2032) ($MN)
  • Table 82 Asia Pacific Embolization Particle Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 83 Asia Pacific Embolization Particle Market Outlook, By Material (2024-2032) ($MN)
  • Table 84 Asia Pacific Embolization Particle Market Outlook, By Biodegradable (2024-2032) ($MN)
  • Table 85 Asia Pacific Embolization Particle Market Outlook, By Non-biodegradable (2024-2032) ($MN)
  • Table 86 Asia Pacific Embolization Particle Market Outlook, By Application (2024-2032) ($MN)
  • Table 87 Asia Pacific Embolization Particle Market Outlook, By Oncology (2024-2032) ($MN)
  • Table 88 Asia Pacific Embolization Particle Market Outlook, By Urology (2024-2032) ($MN)
  • Table 89 Asia Pacific Embolization Particle Market Outlook, By Neurology (2024-2032) ($MN)
  • Table 90 Asia Pacific Embolization Particle Market Outlook, By Peripheral Vascular Disease (2024-2032) ($MN)
  • Table 91 Asia Pacific Embolization Particle Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 92 Asia Pacific Embolization Particle Market Outlook, By End User (2024-2032) ($MN)
  • Table 93 Asia Pacific Embolization Particle Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 94 Asia Pacific Embolization Particle Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 95 Asia Pacific Embolization Particle Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 96 Asia Pacific Embolization Particle Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 97 South America Embolization Particle Market Outlook, By Country (2024-2032) ($MN)
  • Table 98 South America Embolization Particle Market Outlook, By Product (2024-2032) ($MN)
  • Table 99 South America Embolization Particle Market Outlook, By Radioembolization Spheres (2024-2032) ($MN)
  • Table 100 South America Embolization Particle Market Outlook, By Microspheres (2024-2032) ($MN)
  • Table 101 South America Embolization Particle Market Outlook, By Drug Eluting Beads (DEBs) (2024-2032) ($MN)
  • Table 102 South America Embolization Particle Market Outlook, By Gelfoam Particles (2024-2032) ($MN)
  • Table 103 South America Embolization Particle Market Outlook, By Gelatin Sponge Particles (2024-2032) ($MN)
  • Table 104 South America Embolization Particle Market Outlook, By Liquid Embolics (2024-2032) ($MN)
  • Table 105 South America Embolization Particle Market Outlook, By Polyvinyl Alcohol (PVA) Particles (2024-2032) ($MN)
  • Table 106 South America Embolization Particle Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 107 South America Embolization Particle Market Outlook, By Material (2024-2032) ($MN)
  • Table 108 South America Embolization Particle Market Outlook, By Biodegradable (2024-2032) ($MN)
  • Table 109 South America Embolization Particle Market Outlook, By Non-biodegradable (2024-2032) ($MN)
  • Table 110 South America Embolization Particle Market Outlook, By Application (2024-2032) ($MN)
  • Table 111 South America Embolization Particle Market Outlook, By Oncology (2024-2032) ($MN)
  • Table 112 South America Embolization Particle Market Outlook, By Urology (2024-2032) ($MN)
  • Table 113 South America Embolization Particle Market Outlook, By Neurology (2024-2032) ($MN)
  • Table 114 South America Embolization Particle Market Outlook, By Peripheral Vascular Disease (2024-2032) ($MN)
  • Table 115 South America Embolization Particle Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 116 South America Embolization Particle Market Outlook, By End User (2024-2032) ($MN)
  • Table 117 South America Embolization Particle Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 118 South America Embolization Particle Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 119 South America Embolization Particle Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 120 South America Embolization Particle Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 121 Middle East & Africa Embolization Particle Market Outlook, By Country (2024-2032) ($MN)
  • Table 122 Middle East & Africa Embolization Particle Market Outlook, By Product (2024-2032) ($MN)
  • Table 123 Middle East & Africa Embolization Particle Market Outlook, By Radioembolization Spheres (2024-2032) ($MN)
  • Table 124 Middle East & Africa Embolization Particle Market Outlook, By Microspheres (2024-2032) ($MN)
  • Table 125 Middle East & Africa Embolization Particle Market Outlook, By Drug Eluting Beads (DEBs) (2024-2032) ($MN)
  • Table 126 Middle East & Africa Embolization Particle Market Outlook, By Gelfoam Particles (2024-2032) ($MN)
  • Table 127 Middle East & Africa Embolization Particle Market Outlook, By Gelatin Sponge Particles (2024-2032) ($MN)
  • Table 128 Middle East & Africa Embolization Particle Market Outlook, By Liquid Embolics (2024-2032) ($MN)
  • Table 129 Middle East & Africa Embolization Particle Market Outlook, By Polyvinyl Alcohol (PVA) Particles (2024-2032) ($MN)
  • Table 130 Middle East & Africa Embolization Particle Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 131 Middle East & Africa Embolization Particle Market Outlook, By Material (2024-2032) ($MN)
  • Table 132 Middle East & Africa Embolization Particle Market Outlook, By Biodegradable (2024-2032) ($MN)
  • Table 133 Middle East & Africa Embolization Particle Market Outlook, By Non-biodegradable (2024-2032) ($MN)
  • Table 134 Middle East & Africa Embolization Particle Market Outlook, By Application (2024-2032) ($MN)
  • Table 135 Middle East & Africa Embolization Particle Market Outlook, By Oncology (2024-2032) ($MN)
  • Table 136 Middle East & Africa Embolization Particle Market Outlook, By Urology (2024-2032) ($MN)
  • Table 137 Middle East & Africa Embolization Particle Market Outlook, By Neurology (2024-2032) ($MN)
  • Table 138 Middle East & Africa Embolization Particle Market Outlook, By Peripheral Vascular Disease (2024-2032) ($MN)
  • Table 139 Middle East & Africa Embolization Particle Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 140 Middle East & Africa Embolization Particle Market Outlook, By End User (2024-2032) ($MN)
  • Table 141 Middle East & Africa Embolization Particle Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 142 Middle East & Africa Embolization Particle Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 143 Middle East & Africa Embolization Particle Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 144 Middle East & Africa Embolization Particle Market Outlook, By Other End Users (2024-2032) ($MN)